Melanotan II research explained

Melanotan II Research: Structure and Laboratory Studies

Melanotan II Research: Structure and Laboratory Studies

Research only. All AVM Labs USA products are sold strictly for laboratory research. Nothing on this page is medical advice, and nothing here describes use in humans or animals.

Melanotan II is one of the most searched research peptides in the scientific literature. This guide explains it the way the laboratory literature does: its molecular structure, how it is synthesized and characterized, and how to read the studies that mention it.

What Melanotan II is, in laboratory terms

Melanotan II is a synthetic peptide studied in the melanocortin receptor literature. It is a cyclic heptapeptide — a chain of seven amino acids joined into a ring — built as an analogue of alpha-MSH (alpha-melanocyte-stimulating hormone), the natural peptide that activates melanocortin receptors. Unlike the linear peptides in most research catalogues, Melanotan II has no free ends: its ring is closed by a chemical bridge.

In the published literature it is described as a non-selective agonist at melanocortin receptors in assay systems, with activity across several receptor subtypes, including MC1R, MC3R, MC4R and MC5R — which is how research papers identify it. It was developed in the melanocortin chemistry program at the University of Arizona in the 1980s, alongside the related cyclic peptide PT-141.

Molecular structure

The reported molecular formula of Melanotan II is C50H69N15O9, with a molecular weight of approximately 1024.18 Da (monoisotopic mass approximately 1023.54 Da). Its sequence is written Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2. Three structural features define it in the literature:

  • A seven-residue ring. The chain is Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys, closed into a ring by a lactam bridge between the side chains of aspartic acid and lysine. Cyclization constrains the shape of the molecule, holding the residues in a fixed arrangement.
  • Two non-standard features. The N-terminus carries an acetyl group (Ac) and a norleucine (Nle) residue, and one phenylalanine is the D-form (D-Phe) rather than the usual L-form.
  • A C-terminal amide. The chain ends in an amide group (-NH2) rather than a free carboxylic acid. That single detail matters in the laboratory: the related cyclic peptide PT-141 shares the same ring and the same seven residues, but ends in a free acid (-OH) and reads approximately 1025.2 Da — about one dalton heavier.

The CAS number is 121062-08-6, with PubChem CID 92432. These are structural facts, reported in the analytical literature — and what a Certificate of Analysis verifies.

Melanotan II is not Melanotan 1, and it is not PT-141

Three names in this family are often confused, and the laboratory tells them apart by structure alone:

  • Melanotan 1 is a linear peptide of 13 amino acids — Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 — with the molecular formula C78H111N21O19 and a molecular weight of approximately 1646.8 Da (CAS 75921-69-6).
  • Melanotan II is a cyclic heptapeptide — seven residues in a ring, C50H69N15O9, approximately 1024.18 Da, C-terminal amide.
  • PT-141 is a cyclic heptapeptide with the same ring and the same seven residues as Melanotan II, but a free-acid C-terminus instead of an amide, at approximately 1025.2 Da.

Different chain lengths, different shapes, different terminal groups, different masses — which is why the molecular weight is the first identity check on a COA, not a detail.

Why the ring matters in the laboratory

Cyclization changes how the molecule behaves in analysis:

  • Chromatography: a cyclic peptide interacts with an HPLC column differently from a linear peptide of similar size, so retention time is part of its identity profile.
  • Mass spectrometry: the ring changes how the molecule fragments, so the MS pattern differs from that of a linear peptide with the same amino acids.
  • Stability in solution: the constrained ring is less flexible than an open chain.

For a researcher reading a COA, the ring is therefore a check: the reported mass, the HPLC trace and the MS data must all be consistent with a cyclic molecule of 1024.18 Da.

How research peptides like Melanotan II are made: solid-phase synthesis and cyclization

Like most research peptides, Melanotan II is produced by solid-phase peptide synthesis (SPPS), with one additional step:

  1. The first amino acid is anchored to a solid resin support.
  2. Amino acids are added one at a time, in the planned sequence, with the growing chain held on the resin.
  3. Protecting groups shield the parts of each amino acid that should not react yet, and are removed at the right step.
  4. The lactam bridge is formed between the aspartic acid and lysine side chains, closing the ring.
  5. The finished cyclic chain is cleaved from the resin and purified.

Because the sequence is built step by step, the laboratory controls exactly which peptide is produced — and can confirm it afterward. Our post on peptide synthesis explains this method in detail.

How Melanotan II is characterized: identity and purity

A research peptide is not defined by its name alone. In the laboratory it is defined by analytical data, typically:

  • Mass spectrometry (MS): confirms the molecular weight matches the intended sequence, including the ring closure and the amide terminus — the observed mass must read 1024.18 Da, not the 1025.2 Da of PT-141 and not the mass of the linear precursor.
  • High-performance liquid chromatography (HPLC): measures purity and reveals impurities.
  • Certificate of Analysis (COA): the laboratory document that reports those results for a specific batch.

When comparing research materials, the COA is the document that matters: same compound, different batch, different data. AVM Labs USA publishes COAs for its research peptides for this reason. Our guide on how to read a peptide COA explains what each field on that document means.

How Melanotan II is studied in the literature

Laboratory research on Melanotan II takes several forms:

  • Structural studies: how the ring holds the residues in place, and how stable the cyclic structure is under different conditions.
  • In vitro receptor assays: measurements of binding and activation at melanocortin receptors (MC1R, MC3R, MC4R, MC5R) in cell-based systems, where conditions are controlled and variables are isolated.
  • Analytical studies: stability, solubility and degradation — how the peptide behaves in solution, at different temperatures, and over time.

Stability and handling in the laboratory

Peptides are sensitive molecules, and laboratory handling reflects that. The topics researchers document include storage temperature, protection from light and moisture, freeze–thaw cycles, and how long a prepared solution remains stable. Our posts on peptide storage and stability and on refrigeration and shipping cover this in detail.

How to read a Melanotan II study

When you open a paper that mentions Melanotan II, check four things first:

  1. What exactly was studied? The compound name, the sequence or identifier, and the source of the material — and whether the paper means Melanotan II, Melanotan 1, or PT-141.
  2. In what model? In vitro assay, animal model, or another setting — and what that model can and cannot show.
  3. At what scale? The number of samples, the controls used, and whether the result was reproduced.
  4. Who funded it, and where was it published? Peer review and disclosure are part of the evidence, not decoration.

For the general background, start with What Are Peptides?

Related research on this blog

  • MOTS-c Research — a small peptide studied in metabolic research: mots-c-research
  • SS-31 Research — a small peptide studied in mitochondrial research: ss-31-research
  • GHK-Cu Research — a peptide studied in skin biology in the scientific literature: ghk-cu-research

Glossary

  • Cyclic peptide: a peptide whose chain is joined into a ring, with no free ends.
  • D-amino acid: the mirror-image form of a standard amino acid, used in synthetic peptide design.
  • Melanocortin receptor: a family of receptors (MC1R, MC3R, MC4R, MC5R and others) studied in the Melanotan II literature.
  • SPPS: solid-phase peptide synthesis, the standard laboratory method for building peptides.
  • HPLC: high-performance liquid chromatography, used to measure purity.
  • Mass spectrometry (MS): used to confirm molecular weight and identity.
  • COA: Certificate of Analysis, the batch document reporting analytical results.
  • In vitro: experiments outside a living organism, e.g. in cell culture.

Frequently asked questions (research framing)

Is Melanotan II the same as Melanotan 1?

No. Melanotan 1 is a linear peptide of 13 amino acids, approximately 1646.8 Da; Melanotan II is a cyclic peptide of 7 amino acids, approximately 1024.18 Da.

How is Melanotan II different from PT-141?

They share the same seven-residue ring, but Melanotan II ends in a C-terminal amide (approximately 1024.18 Da) while PT-141 ends in a free acid (approximately 1025.2 Da).

What does a COA tell me?

It reports the analytical results — identity and purity — for one specific batch, measured by the laboratory that tested it. For Melanotan II, the key identity check is the molecular weight of 1024.18 Da, confirming the cyclic form with the amide terminus.

Where can I learn more?

Start with the posts linked above, and read the primary literature they cite. For storage and handling, see our posts on peptide stability and refrigeration.


Research only. AVM Labs USA products are for laboratory research use only.

Scroll to Top
header ´para el telefono

Welcome back to AVM Labs USA. Sign in below to access your account and continue shopping.

Don’t have an account yet?
Create your AVM Labs USA account before signing in.